In part 2 of her presentation, Dr Jill Huppert, an Associate Professor of pediatrics and obstetrics and gynecology at Cincinnati Children’s Hospital Medical Center, will review the evidence linking vaginal infections and health outcomes to understand the benefits and limitations, for example, sensitivity and specificity, of new diagnostic point-of-care tests, and to discuss the implication of these tests on screening and treating vaginitis.
In part 2 of her presentation, Dr Jill Huppert, an Associate Professor of pediatrics and obstetrics and gynecology at Cincinnati Children’s Hospital Medical Center, will review the evidence linking vaginal infections and health outcomes to understand the benefits and limitations, for example, sensitivity and specificity, of new diagnostic point-of-care tests, and to discuss the implication of these tests on screening and treating vaginitis.
Also available:
Throughout these presentations, and again at the conclusion, you will have the opportunity to request additional information and follow-up from your local Genzyme Diagnostics representative about the OSOM® Trichomonas Rapid Test and OSOM® BVBLUE® Test, by conveniently clicking on the button at the bottom of the slide screens.
Introduction to Office and Operative Hysteroscopy
, Resad Paya Pasic, MD, with co-authors Royshanda C. Smith, MD and Patrick Yeung Jr, MD
Part 1 - Office Hysteroscopy - In this video tutorial we instruct on the setup, equipment and management of office hysteroscopy. The minimal use of anesthesia and the improvements in therapeutic and diagnostic qualities of office hysteroscopy makes it use an attractive alternative to the operating room for both the gynecologic practice and their patients in terms of reduced time and cost efficiencies.
Part 2 - Operative Hysteroscopy This video tutorial will demonstrate the fundamentals including setup and equipment needed to perform office hysteroscopy, the technique of diagnostic hysteroscopy including fluid delivery options and camera orientation inside the uterine cavity and setup, equipment, and technique required to perform operative hysteroscopies, such as polyp or IUD removal.
FDA adds boxed warning to fezolinetant for rare serious liver injury
Published: December 17th 2024 | Updated: December 17th 2024The FDA has added a boxed warning for fezolinetant (VEOZAH; Astellas), highlighting the rare occurrence of serious liver injury in patients taking the menopause treatment.
Read More